3,6,8-Tris(chlorosulfonyl)pyren-1-yl acetate (E2)
While stirring, pyrene E1 (4.352 g, 7.684 mmol) was slowly added to a solution of thi-
onyl chloride (10 mL) containing three drops of N,N-dimethylformamide. The reac-
tion was refluxed for 5 h. The crude product was poured onto an aqueous ice slurry
and dissolved with dichloromethane. The organic layer was separated and concen-
trated in vacuo to obtain a yellow powder (3.312 g, 5.400 mmol, 78%). 1H NMR
(500 MHz, CDCl3) d 9.68 (d, J = 10.0, 1H), 9.62 (s, 1H), 9.51 (d, J = 10.0, 1H), 9.45
(d, J = 9.7, 1H), 8.91 (s, 1H), 8.83 (d, J = 9.7, 1H), and 2.67 (s, 3H); 13C NMR
(500 MHz, CDCl3) d 168.7, 147.2, 140.8, 137.4, 137.2, 133.1, 131.9, 129.9, 128.2,
128.1, 127.6, 126.5, 126.1, 125.5, 125.4, 124.7, 123.4, and 21.3.
Tert-butyl-(2-((6,8-bis(N-(2-((tert-butoxycarbonyl)amino)ethyl)sulfamoyl)-3-
hydroxypyrene)-1-sulfonamido)ethyl)carbamate (E3)
N-boc-ethylenediamine (4.5704 g, 28.52 mmol) was added to a solution of H2O
(2 mL), tetrahydrofuran (4 mL), and acetonitrile (14 mL). While stirring, pyrene E2
(2.184 g, 3.938 mmol) was added. An additional solution of H2O (2 mL), tetrahydro-
furan (4 mL), and acetonitrile (14 mL) was added. The resulting red-violet solution
was stirred for 19 h at room temperature. Consequently, NaOH pellets (0.3 g)
were added to the mixture and stirred for 2.5 h before additional NaOH pellets
(0.4 g) were added. After 1.5 h, 100 mL of chloroform and 100 mL of 1 M NaOH
were added and vigorously shaken (with occasional venting) until the red product
dissolved completely into the aqueous layer. The aqueous solution was washed
with chloroform (200 mL 3 4). The aqueous layer was separated, ice was added
directly to the solution, and then acidified with a chilled solution of HCl (concen-
trated HCl was added directly to the ice in a 1:3 volume ratio). The resulting yellow
precipitate was collected via vacuum filtration and dried under vacuum (3.224 g,
3.643 mmol, 92%). 1H NMR (500 MHz, CD3OD) d 9.21 (s, 1H), 9.18 (d, J = 9.8, 1H),
8.90 (d, J = 9.6, 1H), 8.94 (d, J = 9.8, 1H), 8.80 (d, J = 9.6, 1H), 8.30 (s, 1H), 2.98 (coa-
lescing m, 12H), and 1.15 (coalescing s, 27H).
2,20,20’-((8-Hydroxypyrene-1,3,6-trisulfonyl)tris(azanediyl))tris(ethan-
1-aminium) tris(trifluoroacetate) (1)
Trifluoroacetic acid (10 mL) was diluted with dichloromethane (50 mL) and then
chilled on ice. Pyrene E3 (3.088 g, 3.489 mmol) was then added to the chilled solu-
tion, which was then removed from the ice and stirred for 1 h. The reaction mixture
was concentrated in vacuo. Residual trifluoroacetic acid was co-distilled with 5 3
20 mL dichloromethane and the resulting orange powder was dried further under
high vacuum. For further purification, the powder was dissolved in a solution of
1:19 CH3CN:H2O (v/v) spiked with 0.1% trifluoroacetic acid. The solution was passed
through a 0.2 mm filter and then injected into a preparatory reverse-phase high-per-
formance liquid chromatography instrument where the gradient was set from 5%
CH3CN (aq, 0.1% trifluoroacetic acid) to 90% CH3CN (aq, 0.1% trifluoroacetic
acid) over 30 min. The flow rate was set to 15 mL/min. Pyrene 1 was collected
from 15% to 33% CH3CN. Note that the preparatory reverse-phase high-perfor-
mance liquid chromatography instrument used has a maximum capacity of ꢀ0.8
grams of solute; therefore, the product was divided into 4 equal portions, each
less than 0.8 grams. Each portion was dissolved in 4.5 mL of the solution of 1:19
CH3CN:H2O (v/v), and a total of 4 runs were made to collect the entire batch of prod-
uct. The desired fractions were concentrated in vacuo to obtain a yellow solid (3.201
g, 3.454 mmol, 99%).1H NMR (600 MHz, DMSO-D6) d 9.19 (d, J = 9.7, 1H), 9.15
(s, 1H), 9.02 (d, J = 9.6, 1H), 8.92 (d, J = 9.7, 1H), 8.84 (d, J = 9.6, 1H), 8.76 (broad,
1H), 8.69 (broad, 1H), 8.66 (broad, 1H), 8.41 (s, 1H), 7.90 (broad, 9H), 3.07 (broad q,
J = 5.9, 2H), 3.01 (broad m, 4H), 2.86 and 2.84 (coalescing, 6H); 13C NMR (600 MHz,
1662 Chem 5, 1648–1670, June 13, 2019